1-6 of 6
Liang Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity

Open Access
Sitanshu S. Singh, Raul Calvo, Anju Kumari, Rushikesh V. Sable, Yuhong Fang, Dingyin Tao, Xin Hu, Sarah Gray Castle, Saifun Nahar, Dandan Li, Emily Major, Tino W. Sanchez, Rintaro Kato, Xin Xu, Jian Zhou, Liang Liu, Christopher A. LeClair, Anton Simeonov, Bolormaa Baljinnyam, Mark J. Henderson, Juan Marugan, Udo Rudloff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (12): 1827–1841.
https://doi.org/10.1158/1535-7163.MCT-23-0790
Published: 03 December 2024
View articletitled, Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity
Open the PDF for Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity in another window
Includes: Supplementary data
Journal Articles

Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody–Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function

Available to Purchase
Rui Jin, Liang Liu, Yun Xing, Tao Meng, Lanping Ma, Jinpeng Pei, Ying Cong, Xuesai Zhang, Zhiqiang Ren, Xin Wang, Jingkang Shen, Ker Yu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2340–2352.
https://doi.org/10.1158/1535-7163.MCT-20-0076
Published: 03 November 2020
View articletitled, Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody–Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function
Open the PDF for Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody–Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function in another window
Includes: Supplementary data
Journal Articles

Abstract A194: Transcriptome evaluation of papillary thyroid cancer with TERT promoter mutation

Free
Shih-Ping Cheng, Ming-Nan Chien, Chien-Liang Liu, Yi-Chiung Hsu, Po-Sheng Yang, Jie-Jen Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A194.
https://doi.org/10.1158/1535-7163.TARG-17-A194
Published: 01 January 2018
View articletitled, Abstract A194: Transcriptome evaluation of papillary thyroid cancer with TERT promoter mutation
Journal Articles

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

Free
Z. Alexander Cao, Kathryn E. Bass, Sriram Balasubramanian, Liang Liu, Brian Schultz, Erik Verner, YuQin Dai, Rafael A. Molina, Jack R. Davis, Shawn Misialek, Martin Sendzik, Christine J. Orr, Ling Leung, Ondine Callan, Peter Young, Stacie A. Dalrymple, Joseph J. Buggy
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (7): 1693–1701.
https://doi.org/10.1158/1535-7163.MCT-06-0042
Published: 04 August 2006
View articletitled, CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo
Open the PDF for CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo in another window
Journal Articles

CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo

Free
Joseph J. Buggy, Z. Alexander Cao, Kathryn E. Bass, Erik Verner, Sriram Balasubramanian, Liang Liu, Brian E. Schultz, Peter R. Young, Stacie A. Dalrymple
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (5): 1309–1317.
https://doi.org/10.1158/1535-7163.MCT-05-0442
Published: 26 May 2006
View articletitled, CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo
Open the PDF for CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo in another window
Journal Articles

Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation

Free
Liang Liu, Joel B. Berletch, Jessica G. Green, Mitchell S. Pate, Lucy G. Andrews, Trygve O. Tollefsbol
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (8): 1003–1009.
https://doi.org/10.1158/1535-7163.1003.3.8
Published: 06 August 2004
View articletitled, Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation
Open the PDF for Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation in another window